Literature DB >> 23798378

Clinicopathologic analysis of undifferentiated carcinoma of the gallbladder.

Hyo Jun Park1, Kee-Taek Jang, Dong Wook Choi, Jin Seok Heo, Seong Ho Choi.   

Abstract

BACKGROUND: Undifferentiated carcinoma (UC) of the gallbladder (GB) is a rare malignant neoplasm and there have only been sparse case reports without precise description. We analyzed eight cases of UC of GB and compared with gallbladder carcinoma (GBC) in the aspects of clinicopathologic characteristics and prognosis.
METHODS: We found eight UC cases out of 238 surgically resected GBCs. Patients with stage-matched GBC were selected (1:4) for comparative analysis of the clinicopathologic features and survival of UC.
RESULTS: Histologically, UC cases were composed of four sarcomatoid, two pleomorphic, one small cell, and one osteoclast-like giant cell types. There was no difference between UC and ordinary GBC in clinicopathologic parameters, except for tumor size. It was significantly larger in UC (median; 5.0 cm, ranging 1.3-10.0 cm) compared to GBC (median; 3.0 cm, ranging 1.5-9.0 cm, P = 0.01). UC presented frequent intraluminal polypoid mass (87.5%: 7/8). UC showed significantly poor overall survival rate (37.5%, 37.5% and 18.8% at 1, 3, and 5 years), than GBC (84.4%, 65.6% and 52.1%, respectively) (P = 0.005). Pathologic findings of UC were an independent prognostic factor for poor survival in GBC (HR 7.242, 95% confidence interval: 1.799-29.147).
CONCLUSIONS: Undifferentiated carcinoma of the gallbladder was a rare highly malignant neoplasm and frequently presented a large intraluminal polypoid tumor. It showed a significantly larger tumor size and poorer survival than GBC.
© 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Gallbladder neoplasms; Survival; Undifferentiated carcinoma

Mesh:

Year:  2013        PMID: 23798378     DOI: 10.1002/jhbp.3

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  7 in total

1.  Carcinosarcoma (adenocarcinoma, neuroendocrine carcinoma, undifferentiated carcinoma and chondrosarcoma) of the gallbladder.

Authors:  Kunio Mochizuki; Hideo Hata; Keiichi Naitou; Utaroh Motosugi; Tetsuo Kondo
Journal:  Clin J Gastroenterol       Date:  2019-07-01

2.  Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.

Authors:  Orhun Cig Taskin; Gizem Akkas; Bahar Memis; Ipek Erbarut Seven; Olca Basturk; Kee-Taek Jang; Juan C Roa; Juan Carlos Araya; Enrique Bellolio; Hector Losada; Juan Sarmiento; Serdar Balci; Burcin Pehlivanoglu; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2019-06-08       Impact factor: 4.064

3.  Undifferentiated carcinoma of the gallbladder with endothelial differentiation: A case report and literature review.

Authors:  Yoshitaka Furuya; Kenzo Hiroshima; Takashi Wakahara; Harutoshi Akimoto; Hironobu Yanagie; Kenichi Harigaya; Hiroshi Yasuhara
Journal:  Mol Clin Oncol       Date:  2016-10-05

4.  Undifferentiated carcinoma of the ampulla of Vater.

Authors:  Misuzu Yamada; Daisuke Furukawa; Naoki Yazawa; Hideki Izumi; Yoshihito Masuoka; Taro Mashiko; Yoshiaki Kawaguchi; Masami Ogawa; Yohei Kawashima; Tetsuya Mine; Kenichi Hirabayashi; Toshio Nakagohri
Journal:  Surg Case Rep       Date:  2017-01-06

5.  Incidence and prognosis of undifferentiated cancers of the digestive system: a population-based cohort study.

Authors:  Jingping Qiu; Yan Xin
Journal:  Ann Transl Med       Date:  2021-01

6.  Aggressive behavior of anaplastic undifferentiated carcinoma arising from the hilar bile duct.

Authors:  Masayuki Akita; Eri Maeda; Ryo Ishida; Tatsuya Morikawa; Tohru Nishimura; Koichiro Abe; Akihito Kozuki; Tomohiro Tanaka; Yukihiro Imai; Kunihiko Kaneda
Journal:  Surg Case Rep       Date:  2022-01-17

7.  SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report.

Authors:  Tiemo S Gerber; Abbas Agaimy; Arndt Hartmann; Michael Habekost; Wilfried Roth; Albrecht Stenzinger; Peter Schirmacher; Beate K Straub
Journal:  Diagn Pathol       Date:  2021-06-12       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.